Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 279,400 shares, a decline of 5.5% from the January 15th total of 295,600 shares. Based on an average trading volume of 947,300 shares, […]
Related Keywords
, Armistice Capital , Acadian Asset Management , Renaissance Technologies , Citadel Advisors , Dermata Therapeutics Company Profile , Virtu Financial , Dermata Therapeutics Inc , Nasdaq , Dermata Therapeutics , Get Free Report , Asset Management , Therapeutics Trading Down , Mild To Moderate Psoriasis , Dermata Therapeutics Daily , Nasdaq Drma , Drma , Medical , Stocks , Options , Put , Call ,
comparemela.com © 2020. All Rights Reserved.